REFERENCES
- Neve K A, Seamans J K, Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004; 24: 165–205
- Van Eldick L J, Watterson D M. Calmodulin and Signal Transduction. Academic Press, Inc., New York 1998
- Kawasaki H, Kretsinger R H. Calcium-binding proteins. 1. EF-hands. Protein Profile 1994; 1: 343–517
- Berridge M J, Bootman M D, Lipp P. Calcium-a life and death signal. Nature 1998; 395: 645–648
- Kahn J, Walcheck B, Migaki G I, Jutila M A, Kishimoto T K. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 1998; 92: 809–818
- Li H, Villalobo A. Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor. Biochem J 2002; 362: 499–505
- Belcheva M M, Szucs M, Wang D X, Sadee W, Coscia C J. μ -opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 2001; 276: 33847–33853
- Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C. Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 2000; 275: 32672–32680
- Turner J H, Gelasco A K, Raymond J R. Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: Putative role in receptor phosphorylation by protein kinase C. J Biol Chem 2004; 279: 17027–17037
- Cox B A, Rosser M P, Kozlowski M R, Duwe K M, Neve R L, Neve K A. Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse 1995; 21: 1–9
- Neve K A, Cumbay M G, Thompson K R, Yang R, Buck D C, Watts V J, DuRand C J, Teeter M M. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. Mol Pharmacol 2001; 60: 373–381
- Macey T A, Gurevich V V, Neve K A. Preferential interaction between the dopamine D2 receptor and arrestin2 in neostriatal neurons. Mol Pharmacol 2004; 66: 1635–1642
- Morgenstern J P, Land H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587–3596
- Liu Y, Teeter M M, DuRand C J, Neve K A. Identification of a Zn2 +-binding site on the dopamine D2 receptor. Biochem Biophys Res Commun 2006; 339: 873–879
- Kozell L B, Neve K A. Constitutive activity of a chimeric D2/D1dopamine receptor. Mol Pharmacol 1997; 52: 1137–1149
- Yap K L, Kim J, Truong K, Sherman M, Yuan T, Ikura M. Calmodulin target database. J Struct Funct Genomics 2000; 1: 8–14
- Rhoads A R, Friedberg F. Sequence motifs for calmodulin recognition. FASEB J 1997; 11: 331–340
- David C, Fishburn C S, Monsma F J, Jr., Sibley D R, Fuchs S. Synthesis and processing of D2 dopamine receptors. Biochemistry 1993; 32: 8179–8183
- Fishburn C S, Elazar Z, Fuchs S. Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor. J Biol Chem 1995; 270: 29819–29824
- James P, Vorherr T, Carafoli E. Calmodulin-binding domains: Just two faced or multifaceted?. Trends Biochem Sci 1995; 20: 38–42
- O'Neil K T, DeGrado W F. How calmodulin binds its targets: Sequence independent recognition of amphiphilic alpha-helices. Trends Biochem Sci 1990; 15: 59–64
- De Camilli P, Macconi D, Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 1979; 278: 252–254
- Stoof J C, Kebabian J W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 1981; 294: 366–368
- Choi E Y, Jeong D W, Park K W, Baik J H. G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors. Biochem Biophys Res Commun 1999; 256: 33–40
- Iaccarino C, Samad T A, Mathis C, Kercret H, Picetti R, Borrelli E. Control of lactotrop proliferation by dopamine: Essential role of signaling through D2 receptors and ERKs. Proc Natl Acad Sci USA 2002; 99: 14530–14535
- Luo Y Q, Kokkonen G C, Wang X T, Neve K A, Roth G S. D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 1998; 71: 980–990
- Oak J N, Lavine N, Van Tol H HM. Dopamine D4 and D2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on transactivation of the platelet-derived growth factor receptor. Mol Pharmacol 2001; 60: 92–103
- Welsh G I, Hall D A, Warnes A, Strange P G, Proud C G. Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors. J Neurochem 1998; 70: 2139–2146
- Otani S, Auclair N, Desce J M, Roisin M P, Crepel F. Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci 1999; 19: 9788–9802
- Yan Z, Feng J, Fienberg A A, Greengard P. D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci USA 1999; 96: 11607–11612
- Cai G P, Zhen X C, Uryu K, Friedman E. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D2 dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J Neurosci 2000; 20: 1849–1857
- Wang C, Buck D C, Yang R, Macey T A, Neve K A. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. J Neurochem 2005; 93: 899–909
- Wang D X, Surratt C K, Sadee W. Calmodulin regulation of basal and agonist-stimulated G protein coupling by the μ -opioid receptor (OP3) in morphine-pretreated cells. J Neurochem 2000; 75: 763–771